Wealth Enhancement Advisory Services LLC Invests $208,000 in Integer Holdings Co. (NYSE:ITGR)

Wealth Enhancement Advisory Services LLC purchased a new position in shares of Integer Holdings Co. (NYSE:ITGR) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,570 shares of the medical equipment provider’s stock, valued at approximately $208,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Principal Financial Group Inc. grew its position in Integer by 3.9% in the fourth quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider’s stock worth $24,154,000 after acquiring an additional 6,905 shares in the last quarter. Intech Investment Management LLC raised its holdings in shares of Integer by 51.1% during the 4th quarter. Intech Investment Management LLC now owns 11,767 shares of the medical equipment provider’s stock valued at $1,559,000 after purchasing an additional 3,980 shares in the last quarter. HighTower Advisors LLC raised its holdings in Integer by 1.4% during the fourth quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider’s stock valued at $1,618,000 after buying an additional 166 shares in the last quarter. Cibc World Markets Corp bought a new position in Integer during the fourth quarter valued at about $413,000. Finally, LPL Financial LLC raised its holdings in Integer by 26.0% during the fourth quarter. LPL Financial LLC now owns 44,508 shares of the medical equipment provider’s stock valued at $6,165,000 after buying an additional 9,196 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Performance

NYSE:ITGR opened at $118.46 on Tuesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The firm’s 50-day moving average is $119.67 and its 200-day moving average is $127.19. Integer Holdings Co. has a 52-week low of $104.93 and a 52-week high of $146.36. The company has a market cap of $4.13 billion, a price-to-earnings ratio of 35.26, a PEG ratio of 1.72 and a beta of 0.98.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same quarter last year, the company earned $1.14 earnings per share. The firm’s revenue was up 7.3% on a year-over-year basis. Equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Truist Financial set a $150.00 target price on Integer and gave the company a “buy” rating in a report on Friday, April 25th. Benchmark cut their target price on Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a report on Friday, April 25th. Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and upped their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Finally, Wall Street Zen upgraded shares of Integer from a “sell” rating to a “hold” rating in a report on Monday, May 19th. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Integer presently has a consensus rating of “Moderate Buy” and a consensus target price of $145.00.

Insider Activity at Integer

In related news, Director Donald J. Spence sold 14,739 shares of the firm’s stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director now owns 18,781 shares in the company, valued at $2,260,856.78. This trade represents a 43.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martin C. Maxwell sold 8,720 shares of the firm’s stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director now owns 22,170 shares of the company’s stock, valued at $2,672,815.20. This trade represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 362,434 shares of company stock valued at $44,577,115 over the last quarter. 2.16% of the stock is owned by company insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.